Former President and Chief Executive Officer · CVS HEALTH Corp (CVS)

Karen S. Lynch

FY2024 is the first fiscal year CompBrief holds for Karen S. Lynch as a named executive officer of CVS HEALTH; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$23,431,466

Salary $1,191,781Stock awards $14,399,857

1st of 6 named executive officers at CVS Health by FY2024 total.

6 named officers on file for CVS HEALTH, FY2024

Karen S. Lynch’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 9 equity grants, each cited to its filing
  • CVS’s disclosed peer group of 64 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CVS HEALTH’s whole pay program stands against its peers

  • CVS HEALTH’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CVS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 4, 2025 (DEF 14A).

Free

Get Karen S. Lynch’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Karen S. Lynch compensation by year

CVS HEALTH Summary Compensation Table · the one fiscal year held
In US dollars, as CVS HEALTH reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$1,191,781
Bonus$0
Stock awards$14,399,857
Option awards$3,599,985
Non-equity incentive$2,383,562
Pension and deferred compensation$0
All other$1,856,281
Total$23,431,466

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CVS HEALTH Corp DEF 14A filed April 4, 2025, accession 0001308179-25-000386, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CVS HEALTH Corp filed document, accession 0001308179-25-000386. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2025.

Change-in-control & termination

estimated payments CVS HEALTH discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$9,000,000$22,573,565$199,223$36,462,960
Resignation for good reason, no change in control$9,000,000$22,573,565$199,223$36,462,960

Per the Potential Payments Upon Termination or Change in Control table in CVS HEALTH Corp's FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

CVS HEALTH’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Karen S. Lynch · this pageFormer President and Chief Executive Officer$23,431,466
J. David JoynerPresident and Chief Executive Officer$17,808,792
Prem S. ShahExecutive Vice President and Group President$13,265,855
Tilak MandadiExecutive Vice President Ventures, and Chief Digital, Data, Analytics and Technology Officer$11,361,343
Thomas F. CowheyExecutive Vice President and Chief Financial Officer$7,644,364
Heidi B. CapozziExecutive Vice President and Chief People Officer$6,850,748

Board service

CVS HEALTH board · FY2022

How this board is paid

Company policy: CVS HEALTH pays directors a $83,750 cash retainer and $251,250 in Stock. As stated in CVS HEALTH's FY2022 proxy.

Committees

Executive Committee

The full CVS HEALTH compensation record

free company brief

This page is one person within CVS HEALTH's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CVS HEALTH proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CVS HEALTH's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Karen S. Lynch's compensation dossier · One-time report. No refunds.